ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-158 Cr | ₹-230 Cr | ₹321 Cr | ₹428 Cr | ₹300 Cr |
What is the latest Net Current Assets ratio of ERIS LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-158 Cr |
| Mar2024 | ₹-230 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹428 Cr |
| Mar2021 | ₹300 Cr |
How is Net Current Assets of ERIS LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-158 Cr | Negative | |
| Mar2024 | ₹-230 Cr | Negative | |
| Mar2023 | ₹321 Cr | -24.83 | |
| Mar2022 | ₹428 Cr | 42.51 | |
| Mar2021 | ₹300 Cr | - | |
Compare Net Current Assets of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹20,342.2 Cr | -2.4% | -6.4% | 18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -2.4% |
-6.4% |
18% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses